Literature DB >> 18543080

Significance of SHP-1 and SHP-2 expression in human papillomavirus infected Condyloma acuminatum and cervical cancer.

Xiao-hua Tao1, Jian-gen Shen, Wei-li Pan, Yu-e Dong, Qun Meng, Kenneth V Honn, Rongxian Jin.   

Abstract

Human papillomaviruses (HPVs) are a group of DNA viruses that infect the skin and mucous membranes. Type HPV6/11 is closely related to Condyloma acuminatum, while HPV16/18 is the principal cause of cervical cancer. In this study, we examined the expression of protein tyrosine phosphatases SHP-1 and SHP-2 in Condyloma acuminatum, cervical cancer and the relationship between SHP-1/SHP2 expression and HPV infection. Forty Condyloma acuminatum cases, 20 cervical cancer cases and 20 normal human foreskins were examined for HPV infection by in situ hybridization and the expression of SHP-1 and SHP-2 were examined by immunohistochemistry. Results demonstrated that positive expression rates of HPV6/11, HPV16/18, and HPV31/33 were 98%, 10%, and 7.5% in Condyloma acuminatum, 10%, 85%, and 25% in cervical cancer. Only one normal foreskin demonstrated positive staining for HPV16/18. Positive expression rates of SHP-1 and SHP-2 were 80% and 85% in Condyloma acuminatum, 85% and 90% in cervical cancer. The SHP-1 and SHP-2 expressions were mainly distributed in the prickle layer of Condyloma acuminatum and were diffusely distributed in cervical cancer cells. Only 35% and 30% of foreskins demonstrated weak staining in the basal layer cells. There were statistically significant correlations among the infection of HPV and the expression of SHP-1 and SHP-2 in both Condyloma acuminatum and cervical cancer (P < 0.05). SHP-1 expression has a positive correlation with SHP-2 expression. Our results demonstrate putative roles of SHP-1 and SHP-2 in the progression of both Condyloma acuminatum and cervical cancer after HPV infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18543080      PMCID: PMC4175450          DOI: 10.1007/s12253-008-9065-5

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  34 in total

1.  Deletion of Shp2 in the brain leads to defective proliferation and differentiation in neural stem cells and early postnatal lethality.

Authors:  Yuehai Ke; Eric E Zhang; Kazuki Hagihara; Dongmei Wu; Yuhong Pang; Rüdiger Klein; Tom Curran; Barbara Ranscht; Gen-Sheng Feng
Journal:  Mol Cell Biol       Date:  2007-07-23       Impact factor: 4.272

2.  Activation of a phosphotyrosine phosphatase by tyrosine phosphorylation.

Authors:  W Vogel; R Lammers; J Huang; A Ullrich
Journal:  Science       Date:  1993-03-12       Impact factor: 47.728

Review 3.  Roots and perspectives of contemporary papillomavirus research.

Authors:  H zur Hausen
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

4.  Concerted activity of tyrosine phosphatase SHP-2 and focal adhesion kinase in regulation of cell motility.

Authors:  S Mañes; E Mira; C Gómez-Mouton; Z J Zhao; R A Lacalle; C Martínez-A
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

5.  Development of squamous cell carcinoma by two high-risk human papillomaviruses (HPVs), a novel HPV-67 and HPV-31 from bowenoid papulosis.

Authors:  A Yoneta; T Yamashita; H Y Jin; A Iwasawa; S Kondo; K Jimbow
Journal:  Br J Dermatol       Date:  2000-09       Impact factor: 9.302

6.  Mutation of the hematopoietic cell phosphatase (Hcph) gene is associated with resistance to gamma-irradiation-induced apoptosis in Src homology protein tyrosine phosphatase (SHP)-1-deficient "motheaten" mutant mice.

Authors:  H C Hsu; L D Shultz; X Su; J Shi; P A Yang; M J Relyea; H G Zhang; J D Mountz
Journal:  J Immunol       Date:  2001-01-15       Impact factor: 5.422

7.  nm23-H1 Expression in Squamous Cell Carcinoma of the Head and Neck.

Authors:  John S McDonald; Peter S Gartside; Ljiljana J Pavelic; Jack L Gluckman; Zlatko P Pavelic
Journal:  Pathol Oncol Res       Date:  1996       Impact factor: 3.201

8.  The tyrosine phosphatase Shp2 interacts with NPM-ALK and regulates anaplastic lymphoma cell growth and migration.

Authors:  Claudia Voena; Chiara Conte; Chiara Ambrogio; Elisabetta Boeri Erba; Francesco Boccalatte; Shabaz Mohammed; Ole N Jensen; Giorgio Palestro; Giorgio Inghirami; Roberto Chiarle
Journal:  Cancer Res       Date:  2007-05-01       Impact factor: 12.701

Review 9.  Human papillomavirus and vaccination in cervical cancer.

Authors:  Kung-Liahng Wang
Journal:  Taiwan J Obstet Gynecol       Date:  2007-12       Impact factor: 1.705

Review 10.  The function of the protein tyrosine phosphatase SHP-1 in cancer.

Authors:  Chengyu Wu; Mingzhong Sun; Lijun Liu; G Wayne Zhou
Journal:  Gene       Date:  2003-03-13       Impact factor: 3.688

View more
  8 in total

Review 1.  Different partners, opposite outcomes: a new perspective of the immunobiology of indoleamine 2,3-dioxygenase.

Authors:  Ciriana Orabona; Maria Teresa Pallotta; Ursula Grohmann
Journal:  Mol Med       Date:  2012-07-18       Impact factor: 6.354

2.  SPARCL1, Shp2, MSH2, E-cadherin, p53, ADCY-2 and MAPK are prognosis-related in colorectal cancer.

Authors:  Shu-Jing Yu; Jie-Kai Yu; Wei-Ting Ge; Han-Guang Hu; Ying Yuan; Shu Zheng
Journal:  World J Gastroenterol       Date:  2011-04-21       Impact factor: 5.742

3.  SHP2 is overexpressed and inhibits pSTAT1-mediated APM component expression, T-cell attracting chemokine secretion, and CTL recognition in head and neck cancer cells.

Authors:  Michael S Leibowitz; Raghvendra M Srivastava; Pedro A Andrade Filho; Ann Marie Egloff; Lin Wang; Raja R Seethala; Soldano Ferrone; Robert L Ferris
Journal:  Clin Cancer Res       Date:  2013-01-30       Impact factor: 12.531

4.  Protein tyrosine phosphatase SHP-1 sensitizes EGFR/HER-2 positive breast cancer cells to trastuzumab through modulating phosphorylation of EGFR and HER-2.

Authors:  Yifen Wu; Rong Li; Junyi Zhang; Gang Wang; Bin Liu; Xiaofang Huang; Tao Zhang; Rongcheng Luo
Journal:  Onco Targets Ther       Date:  2015-09-14       Impact factor: 4.147

5.  Gamma tocotrienol targets tyrosine phosphatase SHP2 in mammospheres resulting in cell death through RAS/ERK pathway.

Authors:  Wenyi Gu; Indira Prasadam; Meihua Yu; Fengxia Zhang; Patrick Ling; Yin Xiao; Chengzhong Yu
Journal:  BMC Cancer       Date:  2015-08-28       Impact factor: 4.430

6.  Clinical significance of leukocyte-associated immunoglobulin-like receptor-1 expression in human cervical cancer.

Authors:  Yue Wang; Xueshan Zhang; Fang Miao; Yanning Cao; Jiangnan Xue; Qizhi Cao; Xiaoshu Zhang
Journal:  Exp Ther Med       Date:  2016-10-26       Impact factor: 2.447

Review 7.  Alteration of SHP-1/p-STAT3 Signaling: A Potential Target for Anticancer Therapy.

Authors:  Tzu-Ting Huang; Jung-Chen Su; Chun-Yu Liu; Chung-Wai Shiau; Kuen-Feng Chen
Journal:  Int J Mol Sci       Date:  2017-06-08       Impact factor: 5.923

8.  Immunogenomic Identification for Predicting the Prognosis of Cervical Cancer Patients.

Authors:  Qun Wang; Aurelia Vattai; Theresa Vilsmaier; Till Kaltofen; Alexander Steger; Doris Mayr; Sven Mahner; Udo Jeschke; Helene Hildegard Heidegger
Journal:  Int J Mol Sci       Date:  2021-02-28       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.